Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein

M. Müller, E. Bakos, E. Welker, A. Váradi, Ursula A. Germann, Michael M. Gottesman, Brian S. Morse, Igor B. Roninson, B. Sarkadi

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

The characteristics of P-glycoprotein (MDR1), an ATP-dependent drug extrusion pump responsible for the multidrug resistance of human cancer, were investigated in an in vitro expression system. The wild-type and several mutants of the human MDR1 cDNA were engineered into recombinant baculoviruses and the mutant proteins were expressed in Sf9 insect cells. In isolated cell membrane preparations of the virus-infected cells the MDR1-dependent drug- stimulated ATPase activity, and 8-azido-ATP binding to the MDR1 protein were studied. We found that when lysines 433 and/or 1076 were replaced by methionines in the ATP-binding domains, all these mutations abolished drug- stimulated ATPase activity independent of the MgATP concentrations applied. Photoaffinity labeling with 8-azido-ATP showed that the double lysine mutant had a decreased ATP-binding affinity. In the MDR1 mutant containing a Gly185 to Val replacement we found no significant alteration in the maximum activity of the MDR1-ATPase or in its activation by verapamil and vinblastine, and this mutation did not modify the MgATP affinity or the 8- azido-ATP binding of the transporter either. However, the Gly185 to Val mutation significantly increased the stimulation of the MDR1-ATPase by colchicine and etoposide, while slightly decreasing its stimulation by vincristine. These shifts closely correspond to the effects of this mutation on the drug-resistance profile, as observed in tumor cells. These data indicate that the Sf9-baculovirus expression system for MDR1 provides an efficient tool for examining structure-function relationships and molecular characteristics of this clinically important enzyme.

Original languageEnglish
Pages (from-to)1877-1883
Number of pages7
JournalJournal of Biological Chemistry
Volume271
Issue number4
DOIs
Publication statusPublished - Jan 26 1996

Fingerprint

P-Glycoproteins
Adenosine Triphosphatases
Adenosine Triphosphate
Mutation
Pharmaceutical Preparations
Baculoviridae
P-Glycoprotein
Lysine
Sf9 Cells
Vinblastine
Colchicine
Multiple Drug Resistance
Vincristine
Etoposide
Mutant Proteins
Cell membranes
Verapamil
Viruses
Drug Resistance
Methionine

ASJC Scopus subject areas

  • Biochemistry

Cite this

Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein. / Müller, M.; Bakos, E.; Welker, E.; Váradi, A.; Germann, Ursula A.; Gottesman, Michael M.; Morse, Brian S.; Roninson, Igor B.; Sarkadi, B.

In: Journal of Biological Chemistry, Vol. 271, No. 4, 26.01.1996, p. 1877-1883.

Research output: Contribution to journalArticle

Müller, M. ; Bakos, E. ; Welker, E. ; Váradi, A. ; Germann, Ursula A. ; Gottesman, Michael M. ; Morse, Brian S. ; Roninson, Igor B. ; Sarkadi, B. / Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein. In: Journal of Biological Chemistry. 1996 ; Vol. 271, No. 4. pp. 1877-1883.
@article{7b45f5237c02493b8e2cd29fd1f0c724,
title = "Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein",
abstract = "The characteristics of P-glycoprotein (MDR1), an ATP-dependent drug extrusion pump responsible for the multidrug resistance of human cancer, were investigated in an in vitro expression system. The wild-type and several mutants of the human MDR1 cDNA were engineered into recombinant baculoviruses and the mutant proteins were expressed in Sf9 insect cells. In isolated cell membrane preparations of the virus-infected cells the MDR1-dependent drug- stimulated ATPase activity, and 8-azido-ATP binding to the MDR1 protein were studied. We found that when lysines 433 and/or 1076 were replaced by methionines in the ATP-binding domains, all these mutations abolished drug- stimulated ATPase activity independent of the MgATP concentrations applied. Photoaffinity labeling with 8-azido-ATP showed that the double lysine mutant had a decreased ATP-binding affinity. In the MDR1 mutant containing a Gly185 to Val replacement we found no significant alteration in the maximum activity of the MDR1-ATPase or in its activation by verapamil and vinblastine, and this mutation did not modify the MgATP affinity or the 8- azido-ATP binding of the transporter either. However, the Gly185 to Val mutation significantly increased the stimulation of the MDR1-ATPase by colchicine and etoposide, while slightly decreasing its stimulation by vincristine. These shifts closely correspond to the effects of this mutation on the drug-resistance profile, as observed in tumor cells. These data indicate that the Sf9-baculovirus expression system for MDR1 provides an efficient tool for examining structure-function relationships and molecular characteristics of this clinically important enzyme.",
author = "M. M{\"u}ller and E. Bakos and E. Welker and A. V{\'a}radi and Germann, {Ursula A.} and Gottesman, {Michael M.} and Morse, {Brian S.} and Roninson, {Igor B.} and B. Sarkadi",
year = "1996",
month = "1",
day = "26",
doi = "10.1074/jbc.271.4.1877",
language = "English",
volume = "271",
pages = "1877--1883",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "4",

}

TY - JOUR

T1 - Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein

AU - Müller, M.

AU - Bakos, E.

AU - Welker, E.

AU - Váradi, A.

AU - Germann, Ursula A.

AU - Gottesman, Michael M.

AU - Morse, Brian S.

AU - Roninson, Igor B.

AU - Sarkadi, B.

PY - 1996/1/26

Y1 - 1996/1/26

N2 - The characteristics of P-glycoprotein (MDR1), an ATP-dependent drug extrusion pump responsible for the multidrug resistance of human cancer, were investigated in an in vitro expression system. The wild-type and several mutants of the human MDR1 cDNA were engineered into recombinant baculoviruses and the mutant proteins were expressed in Sf9 insect cells. In isolated cell membrane preparations of the virus-infected cells the MDR1-dependent drug- stimulated ATPase activity, and 8-azido-ATP binding to the MDR1 protein were studied. We found that when lysines 433 and/or 1076 were replaced by methionines in the ATP-binding domains, all these mutations abolished drug- stimulated ATPase activity independent of the MgATP concentrations applied. Photoaffinity labeling with 8-azido-ATP showed that the double lysine mutant had a decreased ATP-binding affinity. In the MDR1 mutant containing a Gly185 to Val replacement we found no significant alteration in the maximum activity of the MDR1-ATPase or in its activation by verapamil and vinblastine, and this mutation did not modify the MgATP affinity or the 8- azido-ATP binding of the transporter either. However, the Gly185 to Val mutation significantly increased the stimulation of the MDR1-ATPase by colchicine and etoposide, while slightly decreasing its stimulation by vincristine. These shifts closely correspond to the effects of this mutation on the drug-resistance profile, as observed in tumor cells. These data indicate that the Sf9-baculovirus expression system for MDR1 provides an efficient tool for examining structure-function relationships and molecular characteristics of this clinically important enzyme.

AB - The characteristics of P-glycoprotein (MDR1), an ATP-dependent drug extrusion pump responsible for the multidrug resistance of human cancer, were investigated in an in vitro expression system. The wild-type and several mutants of the human MDR1 cDNA were engineered into recombinant baculoviruses and the mutant proteins were expressed in Sf9 insect cells. In isolated cell membrane preparations of the virus-infected cells the MDR1-dependent drug- stimulated ATPase activity, and 8-azido-ATP binding to the MDR1 protein were studied. We found that when lysines 433 and/or 1076 were replaced by methionines in the ATP-binding domains, all these mutations abolished drug- stimulated ATPase activity independent of the MgATP concentrations applied. Photoaffinity labeling with 8-azido-ATP showed that the double lysine mutant had a decreased ATP-binding affinity. In the MDR1 mutant containing a Gly185 to Val replacement we found no significant alteration in the maximum activity of the MDR1-ATPase or in its activation by verapamil and vinblastine, and this mutation did not modify the MgATP affinity or the 8- azido-ATP binding of the transporter either. However, the Gly185 to Val mutation significantly increased the stimulation of the MDR1-ATPase by colchicine and etoposide, while slightly decreasing its stimulation by vincristine. These shifts closely correspond to the effects of this mutation on the drug-resistance profile, as observed in tumor cells. These data indicate that the Sf9-baculovirus expression system for MDR1 provides an efficient tool for examining structure-function relationships and molecular characteristics of this clinically important enzyme.

UR - http://www.scopus.com/inward/record.url?scp=0030026629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030026629&partnerID=8YFLogxK

U2 - 10.1074/jbc.271.4.1877

DO - 10.1074/jbc.271.4.1877

M3 - Article

VL - 271

SP - 1877

EP - 1883

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 4

ER -